Skip to main content
. 2023 Jan 24;13:1092704. doi: 10.3389/fimmu.2022.1092704

Figure 3.

Figure 3

Mobilization of circulating EPCs following FCM application. (A) Levels of circulating CD45lowCD34+KDR+ EPCs in healthy controls and HF patients at baseline and three hours after FCM application as assessed by flow cytometry. *p < 0.05 vs. healthy controls. (B) Time course analysis of CD45lowCD34+KDR+ EPCs in HF patients at baseline and following FCM exposure. *p < 0.05 vs. baseline. (C) Time course analysis of EMV/EPC ratio in HF patients. *p < 0.05 vs. baseline.